Literature DB >> 10660813

Managing pediatric atopic dermatitis.

S S Raimer1.   

Abstract

Although atopic dermatitis is a very common inflammatory skin condition in children and results in many pediatric healthcare visits, its exact cause is unknown. No single laboratory test can reliably diagnose atopic dermatitis, but a relatively simple set of diagnostic criteria was recently validated for use by practicing physicians. Because existing remedies for atopic dermatitis do not cure the disorder, a program of disease control and management should be pursued. Patients and their caregivers should be advised that current therapies are primarily preventive and palliative. However, a comprehensive plan that includes routine general skin care, medical management of symptoms, identification and avoidance of aggravating factors (including psychological factors), and attention to quality-of-life issues can reduce the occurrence of skin flares. Successful treatment of acute flare-ups can be achieved with appropriate use of topical corticosteroids, but occasionally children afflicted with severe atopic dermatitis require more intensive therapies (e.g., ultraviolet light exposure systemic corticosteroids, and cyclosporine) that need close physician monitoring. Physicians must remain mindful of the psychological and quality-of-life burdens imposed on children with atopic dermatitis and their families and tailor treatments to the needs of each individual patient.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10660813     DOI: 10.1177/000992280003900101

Source DB:  PubMed          Journal:  Clin Pediatr (Phila)        ISSN: 0009-9228            Impact factor:   1.168


  6 in total

1.  [Long term management of childhood atopic dermatitis with calcineurin inhibitors].

Authors:  D Thaçi
Journal:  Hautarzt       Date:  2003-04-04       Impact factor: 0.751

2.  Topical Lyogel Containing Corticosteroid Decreases IgE Expression and Enhances the Therapeutic Efficacy Against Atopic Eczema.

Authors:  Shiow-Fern Ng; Nurul-Asmaa Anuwi; Tengku-Noraisyah Tengku-Ahmad
Journal:  AAPS PharmSciTech       Date:  2014-12-16       Impact factor: 3.246

Review 3.  Treatment of atopic dermatitis and impact on quality of life: a review with emphasis on topical non-corticosteroids.

Authors:  Roman Schiffner; Julia Schiffner-Rohe; Michael Landthaler; Wilhelm Stolz
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

Review 4.  Fusidic acid resistance in Staphylococcus aureus.

Authors:  D Dobie; J Gray
Journal:  Arch Dis Child       Date:  2004-01       Impact factor: 3.791

Review 5.  Personalized Immunomodulatory Therapy for Atopic Dermatitis: An Allergist's View.

Authors:  Dong-Ho Nahm
Journal:  Ann Dermatol       Date:  2015-07-29       Impact factor: 1.444

6.  Effect of synbiotic supplementation on children with atopic dermatitis: an observational prospective study.

Authors:  M Dolores Ibáñez; Pablo Rodríguez Del Río; Diego González-Segura Alsina; Vicenç Villegas Iglesias
Journal:  Eur J Pediatr       Date:  2018-09-26       Impact factor: 3.183

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.